- Headquarters
- Saint-Herblain, France · Europe
- Value chain
- Medicines & vaccines(Products); also Research & IP
- What that means
- Develops and sells therapeutics under its own name: drugs, biologics, vaccines, cell and gene therapies and radiopharmaceuticals.
- Founded
- 2013
- Ownership
- Listed
- Listing
- EPA:VLA on Google Finance
- Website
- valneva.com
- Relevance
- Moderate at its strongest, in Advanced Therapeutics, Vaccines & Medical Countermeasures
Saint-Herblain, FranceIn 1 capability
Each capability the company is listed in, most relevant first: how experts in the field see its global relevance there, why it is listed and the source.
Biotechnology & Health Technologies · Design · listed #32 of 50
Developed Ixchiq, the first approved chikungunya vaccine, the inactivated VLA2001 COVID-19 vaccine, and a Lyme disease vaccine candidate with Pfizer.
Relevance: Specialist travel vaccine developer